Prevalence of traditional cardiac risk factors and secondary prevention among patients hospitalized for acute myocardial infarction (AMI): Variation by age, sex, and race

Journal of Women's Health

Volumn 22, Issue 8, 2013, Pages 659-666

  Leifheit Limson, Erica C ^a   Spertus, John A ^b,c   Reid, Kimberly J ^b   Jones, Sara B ^a   Vaccarino, Viola ^d   Krumholz, Harlan M ^a,e   Lichtman, Judith H ^a  

^a YALE UNIVERSITY   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^d EMORY UNIVERSITY   (United States)

^e YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; DIABETES EDUCATION; DIABETES MELLITUS; DIET; FEMALE; GLYCEMIC CONTROL; HOSPITAL DISCHARGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEGRO; OBESITY; PATIENT COUNSELING; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; SECONDARY PREVENTION; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; WEIGHT CONTROL;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; COUNSELING; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HOSPITALIZATION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SECONDARY PREVENTION; SEX FACTORS; SMOKING; SMOKING CESSATION; SOCIOECONOMIC FACTORS;

EID: 84881538905     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2012.3962     Document Type: Article

References (27)

1. U.S. Department of Health and Human Services. Office of Disease Prevention and Health Promotion. Healthy People 2020. Available at http://healthypeople.gov (accessed October 1, 2011).
2. Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction. Circulation 2010;121:586-613.
3. Lloyd-Jones DM, Dyer AR, Wang R, Daviglus ML, Greenland P. Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (Chicago Heart Association Detection Project in Industry). Am J Cardiol 2007; 99: 535-540.
4. Yusuf HR, Giles WH, Croft JB, Anda RF, Casper ML. Impact of multiple risk factor profiles on determining cardiovascular disease risk. Prev Med 1998;27:1-9.
5. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update. Circulation 2012;125:e12-e230.
6. Anderson JL, Adams CD, Antman EM, et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011;123:e426-e579.
7. Kushner FG, Hand M, Smith SC, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update). Circulation 2009;120:2271-2306.
8. Smith SC, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011;124:2458-2473.
9. Canto JG, Kiefe CI, Rogers WJ, et al. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA 2011;306:2120-2127.
10. Canto JG, Kiefe CI, Rogers WJ, et al. Atherosclerotic risk factors and their association with hospital mortality among patients with first myocardial infarction (from the National Registry of Myocardial Infarction). Am J Cardiol 2012;110: 1256-1261.
11. Gerber Y, Weston SA, Killian JM, Jacobsen SJ, Roger VL. Sex and classic risk factors after myocardial infarction: A community study. Am Heart J 2006;152:461-468.
12. Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003;290:891-897.
13. Roe MT, Halabi AR, Mehta RH, et al. Documented traditional cardiovascular risk factors and mortality in non-ST-segment elevation myocardial infarction. Am Heart J 2007; 153:507-514.
14. Spertus JA, Peterson E, Rumsfeld JS, Jones PG, Decker C, Krumholz H. The Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)-Evaluating the impact of myocardial infarction on patient outcomes. Am Heart J 2006;151:589-597.
15. Poirier P, Giles TD, Bray GA, et al.: Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113: 898-918.
16. Schuit AJ, van Loon AJM, Tijhuis M, Ocké MC. Clustering of lifestyle risk factors in a general adult population. Prev Med 2002;35:219-224.
17. Botkin NF, Spencer FA, Goldberg RJ, Lessard D, Yarzebski J, Gore JM. Changing trends in the long-term prognosis of patients with acute myocardial infarction: A population-based perspective. Am Heart J 2006;151:199-205.
18. Masoudi FA, Foody JM, Havranek EP, et al. Trends in acute myocardial infarction in 4 US states between 1992 and 2001: Clinical characteristics, quality of care, and outcomes. Circulation 2006;114:2806-2814.
19. Michaels AD.The secondary prevention of myocardial infarction. Curr Probl Cardiol 1999;24:617-677.
20. Siegel D, Grady D, Browner WS, Hulley SB. Risk factor modification after myocardial infarction. Ann Intern Med 1988;109:213-218.
21. Brown DW, Croft JB, Schenck AP, Malarcher AM, Giles WH, Simpson RJ, Jr. Inpatient smoking-cessation counseling and all-cause mortality among the elderly. Am J Prev Med 2004; 26:112-118.
22. Fonarow GC, French WJ, Parsons LS, Sun H, Malmgren JA. Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: Data from the National Registry of Myocardial Infarction 3. Circulation 2001;103:38-44.
23. Rathore SS, Berger AK, Weinfurt KP, et al. Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly. Circulation 2000;102:642-648.
24. Sonel AF, Good CB, Mulgund J, et al. Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: Insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines?). Circulation 2005;111:1225-1232.
25. Vaccarino V, Rathore SS, Wenger NK, et al. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med 2005;353: 671-682.
26. Nicholson JM, Hennrikus DJ, Lando HA, McCarty MC, Vessey J. Patient recall versus physician documentation in report of smoking cessation counselling performed in the inpatient setting. Tob Control 2000;9:382-388.
27. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: A report from the American Heart Association. Circulation 2013;127:e6-e245.